On 10/1/25, Adverum Biotechnologies Inc (NASDAQ: ADVM) stock enjoyed a major increase of 10.6%, closing at $5.01. Moreover, above average trading volume at 127% of normal accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 23.4% during the last week.
Current PriceTarget Research Rating
Adverum Biotechnologies has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Adverum Biotechnologies has a poor Appreciation Score of 29 and a very low Power Rating of 10, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment